Denali Therapeutics DNLI
$ 21.56
0.33%
Quarterly report 2024-Q3
added 11-06-2024
Denali Therapeutics Financial Statements 2011-2024 | DNLI
Annual Financial Statements Denali Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.36 B | 3.96 B | 7.82 B | 2.23 B | 1.75 B | 354 M | - | - | - | - | - | - |
Shares |
126 M | 122 M | 109 M | 95.6 M | 92.6 M | 15 M | - | - | - | - | - | - |
Historical Prices |
26.8 | 32.6 | 71.8 | 19.8 | 21.8 | 22.9 | - | - | - | - | - | - |
Net Income |
-326 M | -291 M | 71.1 M | -198 M | -36.2 M | -88.2 M | -86.7 M | -16.8 M | - | - | - | - |
Revenue |
108 M | 48.7 M | 336 M | 26.7 M | 129 M | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-341 M | -296 M | 62.7 M | -213 M | -46.4 M | -90.1 M | -87.4 M | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-330 M | -287 M | 71.2 M | -205 M | -39 M | -87.1 M | -86 M | -16.6 M | - | - | - | - |
Operating Expenses |
449 M | 344 M | 273 M | 240 M | 176 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
90.5 M | 79.1 M | 60.3 M | 46.5 M | 32.3 M | 15.7 M | 11.7 M | 5.11 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Denali Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
169 M | 169 M | 149 M | 138 M | 138 M | 137 M | 137 M | 136 M | 123 M | 123 M | 123 M | 122 M | 122 M | 121 M | 121 M | 121 M | 107 M | 106 M | 102 M | 96.1 M | 95.9 M | 95.5 M | 95 M | 94.3 M | 93.7 M | 92.9 M | 89.6 M | 87.5 M | 10.2 M | 9.67 M | 9.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-107 M | -99 M | -102 M | - | -99.4 M | 183 M | -110 M | - | -103 M | -58.8 M | -65.2 M | - | -84.6 M | -60.7 M | -70 M | - | -58.2 M | -58.8 M | -56.8 M | -54 M | -46.3 M | -58.3 M | -39 M | 77.5 M | -35.4 M | -54.7 M | -23.7 M | -22.9 M | -21.8 M | -22.1 M | -21.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | 1.27 M | 294 M | 35.1 M | - | 3.56 M | 52.5 M | 42.1 M | - | 5.28 M | 22.9 M | 7.92 M | - | 9.39 M | 5.85 M | 3.6 M | 4.67 M | 13.6 M | 4.2 M | 4.2 M | 126 M | 1.2 M | 1.65 M | 641 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-123 M | -117 M | -118 M | - | -114 M | 170 M | -121 M | - | -107 M | -61.4 M | -66.5 M | - | -85.6 M | -61.8 M | -71.2 M | - | -60.1 M | -61.3 M | -60 M | -57.8 M | -50.2 M | -62.8 M | -42.5 M | 74.7 M | -38 M | -57.4 M | -25.7 M | -23.5 M | -22.3 M | -22.6 M | -21.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -116 M | - | - | - | -111 M | - | -101 M | -57.3 M | -64.4 M | - | -79.1 M | -57.5 M | -69.1 M | - | -53.7 M | -57 M | -57.9 M | -57.8 M | -44.2 M | -58.7 M | -40.1 M | 74.7 M | -32.9 M | -54.7 M | -24.9 M | -23.5 M | -20 M | -21.1 M | -21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
123 M | 117 M | 132 M | - | 115 M | 124 M | 156 M | - | 111 M | 114 M | 109 M | - | 90.9 M | 84.8 M | 79.1 M | - | 69.5 M | 67.1 M | 63.6 M | - | 63.8 M | 67 M | 46.7 M | - | 39.2 M | 59 M | 26.4 M | - | 22.3 M | 22.6 M | 21.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
24.9 M | 25.2 M | 25.2 M | - | 25.3 M | 26.1 M | 27.1 M | - | 23.3 M | 21.2 M | 22.5 M | - | 19.3 M | 19 M | 18.9 M | - | 15.8 M | 14 M | 12.6 M | - | 11.2 M | 15.1 M | 9.31 M | - | 8.84 M | 6.9 M | 5.57 M | - | 3.77 M | 3.56 M | 3.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency